Archives

  • 2026-03
  • 2026-02
  • 2026-01
  • 2025-12
  • 2025-11
  • 2025-10
  • 2025-09
  • 2025-08
  • 2025-07

    • ARCA Cy5 EGFP mRNA (5-moUTP): Fluorescently Labeled mRNA ...

    2026-01-29

    ARCA Cy5 EGFP mRNA (5-moUTP): Fluorescently Labeled mRNA for Delivery and Localization Analysis

    Executive Summary: ARCA Cy5 EGFP mRNA (5-moUTP) is a 996-nucleotide, 5-methoxyuridine modified mRNA labeled with Cyanine 5 (Cy5), optimized for advanced mRNA delivery and localization analysis in mammalian systems (APExBIO). The Cy5 label enables direct fluorescent detection of mRNA independent of translation, while the EGFP open reading frame allows assessment of translation efficiency in the same sample. The 1:3 ratio of Cy5-UTP to 5-moUTP balances visibility and cellular tolerance. A proprietary co-transcriptional capping method yields a natural Cap 0 structure, ensuring high translation potential and mimicking processed eukaryotic mRNA (Gao et al., 2024). This product is supplied at 1 mg/mL in 1 mM sodium citrate buffer (pH 6.4) and is widely used as a dual-mode control for mRNA delivery system optimization and innate immune activation suppression studies.

    Biological Rationale

    Messenger RNA (mRNA) delivery is a central challenge in gene therapy and synthetic biology. The ability to track mRNA entry and translation in real time enhances the optimization of delivery vehicles and transfection protocols (Gao et al., 2024). Endogenously, mRNA is processed with a 5' cap and poly(A) tail, features critical for stability and efficient translation in mammalian cells. Incorporation of chemically modified nucleotides, such as 5-methoxyuridine, can reduce innate immune activation and improve mRNA stability (Advancing mRNA Delivery Research). Fluorescent labeling with dyes like Cyanine 5 allows for direct visualization and quantification of mRNA uptake and localization, independent of protein synthesis. The combination of these features in ARCA Cy5 EGFP mRNA (5-moUTP) supports rigorous, quantitative studies of mRNA delivery, localization, and translation efficiency in cell culture models.

    Mechanism of Action of ARCA Cy5 EGFP mRNA (5-moUTP)

    ARCA Cy5 EGFP mRNA (5-moUTP) comprises several engineered features:

    • 5' Cap (Cap 0): Created by co-transcriptional capping, this structure is essential for ribosome recognition and translation initiation in eukaryotes (Gao et al., 2024).
    • 5-Methoxyuridine (5-moUTP) Incorporation: Approximately 75% of uridine sites are replaced with 5-moUTP, reducing activation of innate immune sensors (e.g., RIG-I, TLR7/8) and enhancing translational efficiency in mammalian cells (see also).
    • Cyanine 5 (Cy5) Labeling: Cy5-UTP is incorporated at a 1:3 ratio with 5-moUTP, producing mRNA that emits at 670 nm when excited at 650 nm, enabling direct detection by fluorescence microscopy or flow cytometry.
    • EGFP Coding Sequence: The ORF encodes enhanced green fluorescent protein (EGFP), which emits at 509 nm following successful translation, allowing parallel quantification of mRNA uptake and protein expression.
    • Poly(A) Tail: Included to mimic mature eukaryotic mRNA and support efficient translation.

    This dual-mode design enables researchers to distinguish between delivered mRNA and translated protein, facilitating troubleshooting and optimization of delivery workflows (Next-Gen Tools for mRNA Delivery).

    Evidence & Benchmarks

    • 5-methoxyuridine modified mRNA reduces innate immune activation compared to unmodified mRNA, as demonstrated by decreased cytokine production in mammalian cell models (Gao et al., 2024).
    • Cy5 labeling enables single-molecule resolution of mRNA uptake and subcellular localization via fluorescence microscopy, independent of translation status (Mechanistic Insights).
    • Co-transcriptional capping with Cap 0 structure results in >90% capped transcripts, maximizing translation efficiency and mimicking native mRNA processing (Gao et al., 2024).
    • Dual-mode detection (Cy5-labeled mRNA and EGFP protein) streamlines the identification of delivery bottlenecks in cell culture transfection workflows (Next-Gen Tools for mRNA Delivery).
    • ARCA Cy5 EGFP mRNA (5-moUTP) remains stable at -40°C or below for up to 12 months when stored in 1 mM sodium citrate, pH 6.4 (APExBIO).

    Applications, Limits & Misconceptions

    ARCA Cy5 EGFP mRNA (5-moUTP) is primarily used in:

    • mRNA delivery system benchmarking: Quantifying cellular uptake and translation efficiency in mammalian cells (Revolutionizing Fluorescent mRNA Delivery—this article details foundational applications, while the current article extends the discussion to immune evasion and dual-mode quantification).
    • Localization studies: Mapping intracellular trafficking of delivered mRNA using Cy5 fluorescence, independent of protein expression (Fluorescent Tracking & Delivery—the current article provides updated protocol guidance and immune activation context).
    • Translation efficiency assays: Simultaneous measurement of mRNA uptake (Cy5) and protein output (EGFP) in single-cell or population-level assays.
    • Immune activation suppression studies: Assessing the impact of nucleotide modifications (5-moUTP) on the innate immune response to exogenous mRNA.
    • Multiplexed controls: Serving as a robust positive control in transfection and delivery optimization protocols (APExBIO).

    Common Pitfalls or Misconceptions

    • ARCA Cy5 EGFP mRNA (5-moUTP) is not intended for in vivo therapeutic use; it is strictly for research applications in cell culture systems.
    • The Cy5 signal reports mRNA presence, not translation—EGFP fluorescence must be measured separately to assess protein production.
    • Repeated freeze-thaw cycles degrade mRNA integrity and fluorescence signal; aliquoting and proper storage are essential.
    • RNase contamination can rapidly degrade the product; use RNase-free reagents and consumables.
    • Direct addition to serum-containing media without transfection reagent can result in poor uptake and rapid degradation.

    Workflow Integration & Parameters

    ARCA Cy5 EGFP mRNA (5-moUTP) is supplied at 1 mg/mL in 1 mM sodium citrate buffer (pH 6.4). For optimal results:

    • Dissolve mRNA on ice and avoid vortexing to preserve integrity.
    • Mix with a suitable transfection reagent before addition to cells; optimize reagent:mRNA ratios for each cell type.
    • Use serum-free media during transfection, then replace with serum-containing media after 4–6 hours.
    • Monitor Cy5 fluorescence (Ex 650 nm, Em 670 nm) for mRNA localization, and EGFP fluorescence (Ex 488 nm, Em 509 nm) for translation after 6–24 hours, depending on cell type.
    • Store unused aliquots at -40°C or below; avoid repeated freeze-thaw cycles.

    For additional workflow guidance, see Illuminating the Path for mRNA Delivery, which provides detailed troubleshooting strategies; this article updates those recommendations with specific parameters for the R1009 kit.

    Conclusion & Outlook

    ARCA Cy5 EGFP mRNA (5-moUTP), developed by APExBIO, delivers a versatile, dual-mode assay for quantitative mRNA delivery and translation efficiency analysis in mammalian cell culture. Its 5-methoxyuridine modification minimizes innate immune activation, while Cy5 labeling enables sensitive, direct detection of mRNA uptake. The product sets a new standard for troubleshooting and optimization in mRNA delivery system research. Ongoing advances in synthetic mRNA and delivery technologies will further expand the toolbox for gene expression studies and therapeutic development. For detailed product information and ordering, visit the ARCA Cy5 EGFP mRNA (5-moUTP) product page.